Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.

European Journal of Medicinal Chemistry
Di SongShutao Ma

Abstract

With the increasing incidence of antibiotic resistance, new antibacterial agents having novel mechanisms of action hence are in an urgent need to combat infectious diseases caused by multidrug-resistant (MDR) pathogens. Four novel series of substituted 9-arylalkyl-10-methylacridinium derivatives as FtsZ inhibitors were designed, synthesized and evaluated for their antibacterial activities against various Gram-positive and Gram-negative bacteria. The results demonstrated that they exhibited broad-spectrum activities with substantial efficacy against MRSA and VRE, which were superior or comparable to the berberine, sanguinarine, linezolid, ciprofloxacin and vancomycin. In particular, the most promising compound 15f showed rapid bactericidal properties, which avoid the emergence of drug resistance. However, 15f showed no inhibitory effect on Gram-negative bacteria but biofilm formation study gave possible answers. Further target identification and mechanistic studies revealed that 15f functioned as an effective FtsZ inhibitor to alter the dynamics of FtsZ self-polymerization, which resulted in termination of the cell division and caused cell death. Further cytotoxicity and animal studies demonstrated that 15f not only displayed ef...Continue Reading

References

Nov 26, 2002·The Journal of Biological Chemistry·Tushar K BeuriaDulal Panda
Dec 11, 2003·British Journal of Anaesthesia·K J HardyB A Oppenheim
Jul 31, 2007·Biochemical Pharmacology·Prerna DomadiaDebjani Dasgupta
Feb 16, 2008·Biochemistry·Prerna N DomadiaDebjani Dasgupta
Mar 8, 2008·Nature Reviews. Drug Discovery·Rowena L Lock, Elizabeth J Harry
Apr 17, 2008·Protein Science : a Publication of the Protein Society·Paul Bart NotoLaszlo Otvos
Apr 19, 2008·Science·Masaki OsawaHarold P Erickson
Sep 20, 2008·Science·David J HaydonLloyd G Czaplewski
Aug 15, 2009·Nature Reviews. Microbiology·David W Adams, Jeff Errington
Mar 10, 2010·The Journal of Biological Chemistry·José M AndreuAntonio J Martín-Galiano
Dec 4, 2010·Journal of Medicinal Chemistry·Kunal KumarIwao Ojima
Feb 1, 2011·Molecular Microbiology·David W AdamsJeff Errington
Mar 19, 2011·Expert Opinion on Therapeutic Patents·Divya AwasthiIwao Ojima
Dec 27, 2011·International Journal of Antimicrobial Agents·Ian M GouldGeorg Peters
Jul 4, 2012·Bioorganic & Medicinal Chemistry·Gilles BrackmanTom Coenye
Oct 13, 2012·Bioorganic & Medicinal Chemistry Letters·Ajit ParhiEdmond J LaVoie
Oct 23, 2012·Bioorganic & Medicinal Chemistry Letters·Ajit ParhiEdmond J LaVoie
Nov 7, 2012·Bioorganic & Medicinal Chemistry·Cody KelleyEdmond J LaVoie
Sep 17, 2013·Angewandte Chemie·Kieron M G O'ConnellDavid R Spring
Jan 13, 2017·Chemical Communications : Chem Comm·Mai KishimotoMichito Yoshizawa
Mar 21, 2017·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Michal BečkaMária Kožurková
May 26, 2017·Chemical Biology & Drug Design·Anuradha Sharma, Poonam Piplani
Jun 14, 2017·Angewandte Chemie·Valerio FasanoMichael J Ingleson
Jun 22, 2017·Bioorganic & Medicinal Chemistry Letters·Fang LiuShutao Ma
May 12, 2018·The Journal of Physical Chemistry Letters·David T Hogan, Todd C Sutherland
Oct 20, 2018·The Lancet Infectious Diseases·Ursula TheuretzbacherStephan Harbarth
Mar 9, 2019·Accounts of Chemical Research·Peter VikeslandNi Zhu
Sep 22, 2019·Angewandte Chemie·Lewis C WilkinsFrançois P Gabbaï

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.